GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
C

Cytta CYCA · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.02

—

Close of 6 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in USD, from our data supplier.

FY2024

Revenue

$4,492

FY2015FY2024

Net income

−$4.3m

FY2015FY2024

Free cash flow

−$1.8m

FY2015FY2024

Shareholders' equity

−$237,444

FY2015FY2024

Income statement

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Revenue$4,492$30,059$6,089$94,626$48,513——$3,500
Operating income−$3.9m−$4.6m−$5.1m−$2.6m−$1.3m−$356,541−$820,330−$1.5m
Net income−$4.3m−$4.7m−$5.1m−$2.6m−$1.3m−$509,344−$475,315−$751,313
Diluted earnings per share-0.01-0.01-0.01-0.01-0.00———

Balance sheet

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Total assets$2.2m$2.3m$911,009$1.3m$1.6m$8.9m$8.4m$8.0m
Total liabilities$2.4m$2.6m$449,217$406,810$584,440$479,695$45,560$586,862
Shareholders' equity−$237,444−$260,359$461,792$866,244$999,906$8.5m$8.3m$7.4m
Shares outstanding470m427m380m296m294m———

Cash flow

Fiscal years

FY2024FY2023FY2022FY2021FY2020FY2017FY2016FY2015
Cash from operations−$1.8m−$1.4m−$2.4m−$1.3m−$233,952$299,431$245,058$656,239
Capital spending−$14,707——−$68,414−$133,456———
Free cash flow−$1.8m−$1.4m−$2.4m−$1.4m−$367,408$299,431$245,058$656,239

Latest quarters

By quarter end

Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023
Revenue$400$1,300$1,249$1,249$832—$2,411$8,118
Operating income−$373,000−$579,400−$659,417−$685,018−$1.3m−$914,499−$988,041−$1.6m
Net income−$2.1m$6.2m−$724,119−$762,966−$1.5m−$988,541−$1.1m−$1.7m
Diluted earnings per share-0.000.01-0.00-0.00-0.00-0.00-0.00-0.00
Total assets$5.5m$7.5m$1.8m$2.2m$2.7m$1.4m$1.6m$2.3m
Cash and short-term investments$5.2m$7.1m——————
Debt$306,000$306,000——————
Shareholders' equity$4.0m$6.2m−$924,587−$237,444$105,227−$1.7m−$1.1m−$260,359

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-63.8%—-20.4%
Operating income14.8%—8.6%
Net income18.0%—9.6%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-24628.5%-11927.7%——
Net margin-26027.9%-12336.1%——

Valuation history

At each fiscal year end

FY2024FY2023FY2022FY2021FY2020FY2017FY2016FY2015FY2013FY2012
Price to earnings-2.5-1.9-6.6-60.5-20.9-0.8-0.4-0.0——
Price to sales—295.4—————8.50.60.0

Share price return

Finished calendar years

2025202420232022202120202019201820172016
Return-39%4%-71%-75%350%805%-22%716%185%542%

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 300-to-1 reverse split · 29 Apr 2013
  • 20-for-1 split · 11 Aug 2009
  • 4-for-1 split · 4 Dec 2008

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.